Role in IT decision-making process:Align Business & IT GoalsCreate IT StrategyDetermine IT NeedsManage Vendor RelationshipsEvaluate/Specify Brands or VendorsOther RoleAuthorize PurchasesNot Involved

Work Phone:

Company:

Company Size:

Industry:

Street Address

City:

Zip/postal code

State/Province:

Country:

Occasionally, we send subscribers special offers from select partners. Would you like to receive these special partner offers via e-mail?YesNo

Your registration with Eweek will include the following free email newsletter(s):News & Views

By submitting your wireless number, you agree that eWEEK, its related properties, and vendor partners providing content you view may contact you using contact center technology. Your consent is not required to view content or use site features.

By clicking on the "Register" button below, I agree that I have carefully read the Terms of Service and the Privacy Policy and I agree to be legally bound by all such terms.

The company is raising funds on medical crowd funding site Medstartr, looking toward a fall launch of TruRecord.

The solution is designed to foster better patient outcomes by helping to prevent the 100,000 deaths yearly from drugs that are prescribed properly and 80,000 deaths from those which are not, resulting in $289 billion spent annually on malpractice payouts.

Further reading

There are a few major issues that led Zoeticx to proceed with the development of TruRecord, Thanh Tran, the company’s CEO, told eWEEK, with the first being electronic health record (EHR) limitations.

"Most EHR vendors offer a number of capabilities addressing drug adverse events, however, EMR vendors have serious limitations that cannot be overcome within a foreseeable future," he explained. "EHR vendors support drug adverse events by presenting physicians with texts, alert fatigue. In other words, data is presented, but there is no information that helps health providers reduce the potential for drug adverse events."

Tran explained that while a number of solutions offer similar capability, such as enhancing the capability offered by EHR systems, they operate independently from the existing deployed EHR systems.

"By operating separately from the deployed EHR solutions, without an integrated solution, providers would face other challenges, starting with integration, patient privacy protection," he said.

Tran noted on average, there are 35 new drugs introduced annually in the U.S. These drug introductions require physicians to stay on top of the new medications, as well as all of their effects, in addition to all the existing medications.

"Our audience is care providers," Tran explained. "It would be the providers using the applications to directly impact patient outcomes and start the whole process. The support from providers is critical for TruRecord success."

He said the company’s marketing approach is to provide the solution free of use for physicians, make the solution deployment seamless to eliminate any operational disruption, leverage existing EHR solutions to eliminate any challenges such as privacy protection, HIPPA laws.

"Through this process, we would see the increased need for DNA lab test [which is] where we would draw our revenue," he explained.